NC-Free packaging solutions | Heathcare
NC-Free solutions from Amcor
If you would like to understand more about our wider NC-Free portfolio please contact the team.
If you would like to understand more about our wider NC-Free portfolio please contact the team.
NC-Free solutions from Amcor
Amcor’s innovation and expertise eliminates the potential risk of Nitrosamine formation across the blister portfolio.
Amcor’s technical capabilities and our expertise means we have developed a printing primer which when combined with our internal printing know-how delivers a 100% NC-Free blister lidding solution.
How can Amcor's NC-Free solution work for you?
A completely NC-free offering
The blister lidding combinations have been designed to offer an NC-Free solution from unprinted to printed blister combinations.
Sign up to our newsletter
To stay up to date on our latest products and innovations sign up to our newsletter.
The benefits of our full-service NC-Free solution
Fast and simple implementation
We offer a range of NC-Free lidding materials suitable for differing print technologies.
Product safety
Amcor’s research into the formation of N-Nitrosamines means our technical capabilities and full-service solution allow us to deliver a 100% NC-Free blister lidding solution, offering you peace of mind.
Versatility and cost effectiveness
Orders received can be matched to the most cost-effective NC-Free printing technology.
Partner with Amcor
For technical questions and machine trials, Amcor has a dedicated Field Technical Services team ready to support you, simply contact us for more details.
Oral product range
Find out more about our NC-free supported products
Find out more about our NC-free supported products
The latest NC-Free news
NC-Free, your route to peace of mind solutions in pharmaceutical packaging
February 8, 2021
Following the September 2019 ‘call for review’ by regulatory agencies to identify and mitigate the risks of introduction of nitrosamine impurities to pharmaceutical products, those of us who participate in the healthcare industry became aware of vulnerabilities in the production process.
Following the September 2019 ‘call for review’ by regulatory agencies to identify and mitigate the risks of introduction of nitrosamine impurities to pharmaceutical products, those of us who participate in the healthcare industry became aware of vulnerabilities in the production process.
Senior Product Manager - Healthcare Amcor
Do you want to know more? Get in touch
Tell us more about your product so we can connect you with the right team for your request.
For all other inquiries, please contact us here.
All fields marked with (*) are required.
